Janet B. Serle

Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)

Janet B. Serle, L. Jay Katz, Eugene McLaurin et al. · American Journal of Ophthalmology · 2017 · 260 citations · Full text

Effect of 0.04% AR-13324, a ROCK, and Norepinephrine Transporter Inhibitor, on Aqueous Humor Dynamics in Normotensive Monkey Eyes

Rongfang Wang, Jennifer E. Williamson, Casey Kopczynski et al. · Journal of Glaucoma · 2013 · 124 citations

Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)

Malik Y. Kahook, Janet B. Serle, Francis S. Mah et al. · American Journal of Ophthalmology · 2019 · 114 citations

Maintained Reduction of Intraocular Pressure by Prostaglandin F2α-1-Isopropyl Ester Applied in Multiple Doses in Ocular Hypertensive and Glaucoma Patients

Carl B. Camras, Earlene C. Siebold, Jacqueline S. Lustgarten et al. · Ophthalmology · 1989 · 105 citations

Hypertension, Ocular Disease, Ophthalmology +10

Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study

Albert S Khouri, Janet B. Serle, Jason Bacharach et al. · American Journal of Ophthalmology · 2019 · 103 citations